These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 15238144

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M, Asakura H, Aoshima K, Saito M, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Ikeda T, Matsuda T.
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S.
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T, Furukawa Y, Murakami M, Watanabe K, Kondo M.
    Thromb Haemost; 1982 Oct 29; 48(2):235-7. PubMed ID: 7179203
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
    Yamazaki M, Asakura H, Aoshima K, Saito M, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Ikeda T, Matsuda T.
    Semin Thromb Hemost; 1996 Oct 29; 22(3):255-9. PubMed ID: 8836010
    [Abstract] [Full Text] [Related]

  • 7. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
    Yun-Choi HS, Pyo MK, Chang KC, Lee DH.
    Planta Med; 2002 Apr 29; 68(4):326-9. PubMed ID: 11988856
    [Abstract] [Full Text] [Related]

  • 8. Effects of two tetrahydroisoquinolines (YS-49 and YS-51) on experimental disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Pyo MK, Yun-Choi HS, Chang KC, Lee DH.
    Arzneimittelforschung; 2004 Apr 29; 54(11):705-10. PubMed ID: 15612611
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y, Ota M, Katsuura Y, Komoriya K, Nakagaki T.
    Arzneimittelforschung; 2000 Sep 29; 50(9):809-15. PubMed ID: 11050697
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H.
    Pol J Pharmacol; 1996 Sep 29; 48(2):225-8. PubMed ID: 9112656
    [Abstract] [Full Text] [Related]

  • 12. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Fujita M, Izutani W, Komurasaki Y.
    Thromb Haemost; 2000 Jul 29; 84(1):54-8. PubMed ID: 10928470
    [Abstract] [Full Text] [Related]

  • 13. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T, Kohno Y, Koishi K.
    Am J Emerg Med; 2012 Sep 29; 30(7):1219-23. PubMed ID: 22204993
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW, Mathews KA, Abrams-Ogg AC, Lumsden JH, Johnstone IB, Hillers TK, Foster RA.
    J Am Vet Med Assoc; 1999 Sep 15; 215(6):798-804. PubMed ID: 10496131
    [Abstract] [Full Text] [Related]

  • 15. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
    Lu X, Li W, Wang G, Wang Q, Jiang Y, Gao J, Zhao X, Xu L.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb 15; 27(2):92-6. PubMed ID: 25665605
    [Abstract] [Full Text] [Related]

  • 16. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia].
    Qiao YJ, Zhu JM, You XL, Zhang Y.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar 15; 19(3):165-7. PubMed ID: 17376272
    [Abstract] [Full Text] [Related]

  • 17. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C, Nordfang O, Wildgoose P, Svendsen O, Hedner U, Diness V.
    Blood Coagul Fibrinolysis; 1993 Oct 15; 4(5):699-706. PubMed ID: 8292719
    [Abstract] [Full Text] [Related]

  • 18. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
    Nawa K, Itani T, Ono M, Sakano K, Marumoto Y, Iwamoto M.
    Thromb Haemost; 1992 Mar 02; 67(3):366-70. PubMed ID: 1322570
    [Abstract] [Full Text] [Related]

  • 19. Purified thromboplastin causes haemostatic abnormalities but not overt DIC in an experimental rabbit model.
    Berthelsen LO, Kristensen AT, Tranholm M.
    Thromb Res; 2010 Oct 02; 126(4):337-44. PubMed ID: 20637496
    [Abstract] [Full Text] [Related]

  • 20. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
    Marbet GA, Griffith MJ, Roberts HR.
    Scand J Clin Lab Invest Suppl; 1985 Oct 02; 178():95-8. PubMed ID: 3867125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.